Biotech Beast

Incyte Shares ESMO 2026 Data for Pancreatic, Colorectal, Ovarian Cancers

Incyte's ESMO 2026 data shows promise for pancreatic, colorectal, and ovarian cancer treatments.

Seekingalpha · 1m